Trending Articles

  1. Agarose Bead Technologies marks 25 years with $10m global expansion plan The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities...
  2. MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in...
  3. MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares...
  4. Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial...
  5. Novo Nordisk acquires rights to Omeros’ MASP-3 inhibitor zaltenibart in $2.1bn deal The agreement grants Novo Nordisk exclusive global rights to develop and commercialise the clinical-stage antibody for rare blood and kidney disorders, strengthening its Rare...

You may also like

Finance Acquisition to include Red One solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for...

Lonza to expand bioscience testing offering with the acquisition of Redberry

Read more
Finance The flow chemistry centre of excellence includes more than 100 R&D and manufacturing scientists

Shilpa Medicare opens flow chemistry manufacturing centre

Read more
Finance Cambrex's continued investments underscore its commitment to adding capabilities and increasing capacity to meet the evolving needs and growing demand of the pharmaceutical...

Cambrex unveils $120m investment to expand API manufacturing and strengthen US drug supply resilience

Read more
Finance The investment aligns with the latest EU GMP Annex 1 standards and reinforces Curia’s longstanding commitment to regulatory excellence and product quality

Curia invests $4m to enhance sterile API manufacturing

Read more
Finance The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities...

Agarose Bead Technologies marks 25 years with $10m global expansion plan

Read more
Packaging The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial...

Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe

Read more
Finance The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in...

MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities

Read more
Finance The CDMO's partnership with Curewell will provide significant growth capital to expand WPT’s manufacturing capacity and further scale its end-to-end capabilities in producing...

Wilmington PharmaTech secures further funding for its expansion from Curewell Capital

Read more
Regulatory The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares...

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

Read more
Finance The agreement grants Novo Nordisk exclusive global rights to develop and commercialise the clinical-stage antibody for rare blood and kidney disorders, strengthening its Rare...

Novo Nordisk acquires rights to Omeros’ MASP-3 inhibitor zaltenibart in $2.1bn deal

Read more
Finance The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable...

Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies

Read more
Finance LTS Lohmann Therapie-Systeme has agreed to acquire US-based CDMO Renaissance Lakewood, strengthening its position in nasal spray and sterile dosage form manufacturing and...

LTS expands CDMO footprint with acquisition of Renaissance Lakewood

Read more
Finance Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib

Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib

Read more
Manufacturing Transformation program launched to boost performance and free cash flow

Gerresheimer adjusts 2025 guidance amid slower market growth

Read more
Manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the...

AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing

Read more
Finance Bristol Myers Squibb will acquire Orbital Therapeutics in a $1.5bn deal, adding next-generation RNA-based in vivo CAR T technology to its cell therapy pipeline and expanding...

Bristol Myers Squibb strengthens and diversifies cell therapy portfolio with acquisition of Orbital Therapeutics

Read more